Arkolith/Insider Trading/CAPR/Form 4

Sabar Karimah Es

DirectorCAPRICOR THERAPEUTICS, INC. (CAPR) · full profile →Form 4 · filed Apr 3, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$241K
Net Open-Market Flow
-$241K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)8K$3.18$24K8K
Apr 2, 2026Sell(S)8K$32.00$241K0

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Apr 2, 2026Option exercise(M)8K—$0161

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001873796-26-000006) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML